Advertisement
Advertisement

IVVD

IVVD logo

Invivyd Inc

0.446
USD
-0.044
-8.98%
Dec 18, 15:59 UTC -5
Closed
...

Invivyd Inc Profile

About

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Info & Links

CEO

David Hering

Headquarters

1601 TRAPELO ROAD,SUITE 178
WALTHAM, MA 02451, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

11

Employees

95

Invivyd Inc Statistics

Valuation Measures

Market Capitalization2

53.35M

Enterprise Value

-53.52M

Enterprise Value/EBITDA(ttm)

0.24

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.79

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

46.86%

Operating Margin(ttm)

--

Profit Margin(ttm)

-685.00%

Return on Equity(ttm)

-155.33%

Return on Invested Capital(ttm)

-172.50%

Return on Assets(ttm)

-114.88%

Income Statement

Revenue(ttm)

11.56M

Revenue Per Share(ttm)

0.10

Gross Profit(ttm)

10.67M

EBITDA(ttm)3

-227.15M

Net Income Available to Common(ttm)

-225.14M

Diluted EPS(ttm)

-1.96

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

-74.37%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

119.62M

Dividend Yield

0.00%

Float4

98.20M

% Held by Insiders

17.90%

% Held by Institutions

70.36%

Balance Sheet

Total Cash(mrq)

106.87M

Total Cash Per Share(mrq)

0.89

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.92%

Quick Ratio(mrq)

1.58%

Book Value Per Share(mrq)

0.70

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.11

Free Cash Flow(ytd)

-133.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement